纳斯达克生物科技指数周四收涨3.24%

Rubius Therapeutics涨48.58%领跑，Relay Therapeutics Inc.涨23.75%，Revance Therapeutics涨21.58%，再生元制药公司（REGN）涨18.85%，Olema、IVERIC bio、Terns Pharmaceuticals、Allovir、Rhythm Pharma、NanoString Technologies、Agios Pharmaceuticals、Tonix Pharmaceuticals Holding、Candel Therapeutics、Alx Oncology Holdings、IGM Biosciences、Ikena Oncology、Akero Therapeutics、NRX Pharmaceuticals、Ascendis Pharma A/S涨幅介于18.50%-10.37%，Icosavax则跌9.88%，Leap Therapeutics跌10.86%，Erasca跌11.28%，Spero Therapeutics跌14.69%表现最差。